Kancera ABKancera AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Jump to the end of the page for potential risks for Kancera AB based on industry, geography and size. This assessment of Kancera AB leverages data points from across the internet and also from public filings by Kancera AB. This ESG score includes seventeen United Nations SDGs including: 'Gender Equality', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'.

Kancera AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.1; made up of an environmental score of 6.0, social score of 6.7 and governance score of 5.7.

SDG Transparency Score for Kancera AB 
Low
0 - 3

6.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Kancera AB 
6.0

Environmental

6.7

Social

5.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
586Traphaco JSC
6.2
High
586Xenon Pharmaceuticals Inc
6.2
High
623Kancera AB
6.1
High
623Achieve Life Sciences Inc
6.1
High
623Anatara Lifesciences Ltd
6.1
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Kancera AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Kancera AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Kancera AB report the average age of the workforce?

LockedSign up for free to unlock

Does Kancera AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Kancera AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Kancera AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Kancera AB offer flexible work?

LockedSign up for free to unlock

Does Kancera AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Kancera AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Kancera AB conduct supply chain audits?

LockedSign up for free to unlock

Does Kancera AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Kancera AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Kancera AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Kancera AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Kancera AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Kancera AB disclose water use targets?

LockedSign up for free to unlock

Does Kancera AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Kancera AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Kancera AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Kancera AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Kancera AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Kancera AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Kancera AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Kancera AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Kancera AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Kancera AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Kancera AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Kancera AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Kancera AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Kancera AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Kancera AB disclose its waste policy?

LockedSign up for free to unlock

Does Kancera AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Kancera AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Kancera AB disclose energy use targets?

LockedSign up for free to unlock

Does Kancera AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Kancera AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Kancera AB
These potential risks are based on the size, segment and geographies of the company.

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.

Sorry!

Failed to process!